GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (FRA:RDDA) » Definitions » Effect of Exchange Rate Changes

Dr Reddy's Laboratories (FRA:RDDA) Effect of Exchange Rate Changes : €-1 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Dr Reddy's Laboratories Effect of Exchange Rate Changes?

Dr Reddy's Laboratories's Effect of Exchange Rate Changes for the three months ended in Mar. 2024 was €-1 Mil.

Dr Reddy's Laboratories's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2024 was €-1 Mil.

Dr Reddy's Laboratories Effect of Exchange Rate Changes Historical Data

The historical data trend for Dr Reddy's Laboratories's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Effect of Exchange Rate Changes Chart

Dr Reddy's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.30 1.30 8.74 3.25 -0.65

Dr Reddy's Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.00 -1.00 -0.74 1.77 -0.72

Dr Reddy's Laboratories Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Effect of Exchange Rate Changes Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Effect of Exchange Rate Changes provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (FRA:RDDA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (FRA:RDDA) » Definitions » Effect of Exchange Rate Changes
Comparable Companies
NSE:DIVISLAB BOM:532321 BOM:543904 NSE:TORNTPHARM BOM:500257 NSE:AUROPHARMA NSE:ALKEM BOM:524494 BOM:532296 BOM:506943 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
RDY:USA DRREDDY:India 500124:India RDDA:Germany R1DY34:Brazil
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Website
https://www.drreddys.com
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (FRA:RDDA) Headlines

No Headlines